We demonstrated that the Hsp90 mRNA expression levels in primary and metastatic CRC tissues were similar to those of HMGA2, analyzed from the Gene Expression Omnibus repository (GSE21815), and reported that the Hsp90 inhibitor follows a rational therapeutic approach in inhibiting HMGA2-triggered tumorigenesis. This evidence concerns the gene HMGA2 and colorectal carcinoma.